• Welcome to Specialised Therapeutics
  • SE Asia (HQ)

    +65 3158 9940

  • Australia

    1300 798 820

  • New Zealand

    +64 9801 0299

November 2015 - ICLUSIG® (ponatinib) Reimbursed for Chronic Myeloid Leukaemia (CML)

ST achieves PBS reimbursement for ICLUSIG® (ponatinib) in Australia